Release date: 2013-02-22 Source: China Medical Technology Network) Another benefit of vitamins for the human body is that it can help the growth and development of the human body to operate normally, especially for teenagers, vitamins are one of the essential nutrients in the growth process. For example, vitamin D can well adjust the metabolism of some trace elements in the human body, and can also promote the absorption of calcium by the human body, maintain bone health, and maintain a balance between the blood phosphorus level and the blood calcium level in the human body. Vitamin Efficacy,vitamin drink,The benefits of vitamins,vitamin water YT(Xi'an) Biochem Co., Ltd. , https://www.ytherblife.com
The relevant data showed that the first-phase patency rate at 12 months was 87.7%, and no stent fracture was found.
Recently, IDEV Technologies announced the positive clinical results of the Supera? Peripheral Stent System in the Journal of Cardiovascular Interventions of the American College of Cardiology. "Treatment of Complex Atherosclerotic Popliteal Artery Disease with a New Self-Expanding Interwoven Nitinol Stent: 12-Month Results of the Leipzig Supera Popliteal Registry" by Durek Scheinert, MD, Park Krankenhaus Hospital, Leipzig, Germany.
In the Leipzig study, 101 consecutive patients were implanted with 125 Supera stents and became the subject of the study. Among them, 47.5% were completely occluded patients and 49.5% were diabetic patients. Implanted stents range in length from 40 mm to 240 mm with a mean of 84.3 mm. The patency rate of the first phase at 12 months was 87.7%. No stent fracture was found.
Professor Scheinert said: "The patency rate similar to that of the superficial femoral artery at 12 months after implantation of the severely ill carotid artery confirmed that Supera can be used to treat patients who are not implanted with standard Nitinol stents. No stent fracture was found in the brachial artery, twisted, rotated, and curved, confirming the unique Supera design and the associated advantages of this vascular stent."
To obtain scientifically and clinically meaningful information, the Registry specifically engages patients with a variety of diseases, including long lesions, complete occlusion, and vascular calcification, without prior inclusion and exclusion criteria. Therefore, the selected patients are sufficient to reflect the real situation.
IDEV President and CEO Chris Owens said: "We are very excited to see the results of the Supera stent in the radial artery. We are very excited. The doctors said that the use of Supera to treat femoral hernia is still very effective."
IDEV is currently working with the US Food and Drug Administration (FDA) to conduct a randomized IDE trial in the United States to study radial stent implantation.
Introduction to Supera Brackets Supera stents are designed using proprietary wire mesh technology that simulates vascular anatomy. In the United States, Supera stents are currently used for palliative treatment of malignant tumor-induced biliary strictures, while in many other countries for the treatment of malignant tumor-induced biliary strictures and peripheral percutaneous transluminal angioplasty (PTA) failure Use of blood vessels.